Hastie K.M.Li H.Bedinger D.Schendel S.L.Moses Dennison S.Li K.Rayaprolu V.Yu X.Mann C.Zandonatti M.Avalos R.D.Zyla D.Buck T.Hui S.Shaffer K.Hariharan C.Yin J.Olmedillas E.Enriquez A.Parekh D.Abraha M.Feeney E.Horn G.Q.Aldon Y.Ali H.Aracic S.Cobb R.R.Federman R.S.Fernandez J.M.Glanville J.Green R.Grigoryan G.Lujan Hernandez A.G.Ho D.D.Kuan-Ying A. HuangIngraham J.Jiang W.Kellam P.Kim C.Kim M.Kim H.M.Kong C.Krebs S.J.Lan F.Lang G.Lee S.Leung C.L.Liu J.Lu Y.MacCamy A.McGuire A.T.Palser A.L.Rabbitts T.H.Tehrani Z.R.Sajadi M.M.Sanders R.W.Sato A.K.Schweizer L.Seo J.Shen B.Snitselaar J.L.Stamatatos L.Tan Y.Tomic M.T.van Gils M.J.Youssef S.Yu J.Yuan T.Z.Zhang Q.Peters B.Tomaras G.D.Germann T.Saphire E.O.CoVIC-DB team2023-01-112023-01-1120210036-8075https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116366228&doi=10.1126%2fscience.abh2315&partnerID=40&md5=c597c45fe07b211d0f2175c3e6af827fhttps://scholars.lib.ntu.edu.tw/handle/123456789/627139Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studyjournal article10.1126/science.abh2315345548262-s2.0-85116366228